BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25025768)

  • 1. Inactivating UBE2M impacts the DNA damage response and genome integrity involving multiple cullin ligases.
    Cukras S; Morffy N; Ohn T; Kee Y
    PLoS One; 2014; 9(7):e101844. PubMed ID: 25025768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBE2M Is a Stress-Inducible Dual E2 for Neddylation and Ubiquitylation that Promotes Targeted Degradation of UBE2F.
    Zhou W; Xu J; Tan M; Li H; Li H; Wei W; Sun Y
    Mol Cell; 2018 Jun; 70(6):1008-1024.e6. PubMed ID: 29932898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting neddylation E2s: a novel therapeutic strategy in cancer.
    Zheng YC; Guo YJ; Wang B; Wang C; Mamun MAA; Gao Y; Liu HM
    J Hematol Oncol; 2021 Apr; 14(1):57. PubMed ID: 33827629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of Nedd8‑conjugating enzyme UBE2M suppresses the proliferation and induces the apoptosis of intrahepatic cholangiocarcinoma cells.
    Zhao B; Gao C; Shi D; Mao J; Zhao J; Guo L; Guo J; Jiao Z
    Oncol Rep; 2019 Dec; 42(6):2670-2679. PubMed ID: 31545502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification.
    Xu B; Deng Y; Bi R; Guo H; Shu C; Shah NK; Chang J; Liu G; Du Y; Wei W; Wang C
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):1083-1093. PubMed ID: 29667067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neddylation-CRLs regulate the functions of Treg immune cells.
    Wu D; Sun Y
    Bioessays; 2023 Apr; 45(4):e2200222. PubMed ID: 36709423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Destabilization of CDC6 upon DNA damage is dependent on neddylation but independent of Cullin E3 ligases.
    Tan CY; Hagen T
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1489-98. PubMed ID: 23597704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micafungin: A promising inhibitor of UBE2M in cancer cell growth suppression.
    Mamun MAA; Liu S; Zhao L; Zhao L; Li ZR; Shen D; Zheng Y; Zheng YC; Liu HM
    Eur J Med Chem; 2023 Nov; 260():115732. PubMed ID: 37651876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective ubiquitylation of p21 and Cdt1 by UBCH8 and UBE2G ubiquitin-conjugating enzymes via the CRL4Cdt2 ubiquitin ligase complex.
    Shibata E; Abbas T; Huang X; Wohlschlegel JA; Dutta A
    Mol Cell Biol; 2011 Aug; 31(15):3136-45. PubMed ID: 21628527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ube2m-Rbx1 neddylation-Cullin-RING-Ligase proteins are essential for the maintenance of Regulatory T cell fitness.
    Wu D; Li H; Liu M; Qin J; Sun Y
    Nat Commun; 2022 May; 13(1):3021. PubMed ID: 35641500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proapoptotic effect of WS-299 induced by NOXA accumulation and NRF2-counterbalanced oxidative stress damage through targeting RBX1-UBE2M interaction in gastric cancers.
    Ma T; Song Q; Cheng B; Guo E; Wang X; Li M; Dai M; Li S; Feng S; Yu B
    Bioorg Chem; 2024 Mar; 144():107142. PubMed ID: 38280358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NPRL2 reduces the niraparib sensitivity of castration-resistant prostate cancer via interacting with UBE2M and enhancing neddylation.
    Zhao X; Jiang L; Hu D; Tang Y; Zhao G; Du X; Luo S; Tang W
    Exp Cell Res; 2021 Jun; 403(2):112614. PubMed ID: 33905671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer.
    Li L; Kang J; Zhang W; Cai L; Wang S; Liang Y; Jiang Y; Liu X; Zhang Y; Ruan H; Chen G; Wang M; Jia L
    EBioMedicine; 2019 Jul; 45():81-91. PubMed ID: 31208947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells.
    Lan H; Tang Z; Jin H; Sun Y
    Sci Rep; 2016 Apr; 6():24218. PubMed ID: 27063292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cullin-based E3 ubiquitin ligases in intact mammalian cells--evidence for cullin dimerization.
    Chew EH; Poobalasingam T; Hawkey CJ; Hagen T
    Cell Signal; 2007 May; 19(5):1071-80. PubMed ID: 17254749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NEDD8-conjugating enzyme E2s: critical targets for cancer therapy.
    Zhou L; Lin X; Zhu J; Zhang L; Chen S; Yang H; Jia L; Chen B
    Cell Death Discov; 2023 Jan; 9(1):23. PubMed ID: 36690633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNF111-dependent neddylation activates DNA damage-induced ubiquitination.
    Ma T; Chen Y; Zhang F; Yang CY; Wang S; Yu X
    Mol Cell; 2013 Mar; 49(5):897-907. PubMed ID: 23394999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MLN4924 suppresses neddylation and induces cell cycle arrest, senescence, and apoptosis in human osteosarcoma.
    Zhang Y; Shi CC; Zhang HP; Li GQ; Li SS
    Oncotarget; 2016 Jul; 7(29):45263-45274. PubMed ID: 27223074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus oncoprotein E4orf6 triggers Cullin5 neddylation to activate the CLR5 E3 ligase for p53 degradation.
    Guo H; Shen S; Li Y; Bi R; Zhang N; Zheng W; Deng Y; Yang Y; Yu XF; Wang C; Wei W
    Biochem Biophys Res Commun; 2019 Sep; 516(4):1242-1247. PubMed ID: 31301771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Arabidopsis COP9 signalosome is essential for G2 phase progression and genomic stability.
    Dohmann EM; Levesque MP; De Veylder L; Reichardt I; Jürgens G; Schmid M; Schwechheimer C
    Development; 2008 Jun; 135(11):2013-22. PubMed ID: 18434413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.